Healthcare Third-Party Logistics Market Report 2026

Healthcare Third-Party Logistics Market Overview

• Healthcare Third-Party Logistics market size has reached to $258.69 billion in 2025 • Expected to grow to $401.07 billion in 2030 at a compound annual growth rate (CAGR) of 9.1% • Growth Driver: The Increasing Demand For Vaccines Is Fueling The Growth Of The Market Due To Rising Need For Safe And Timely Distribution • Market Trend: Innovative Platform Transforms Delivery Of Advanced Therapies • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Healthcare Third-Party Logistics Market?

Healthcare third-party logistics (3PL) refers to the outsourcing of logistics and supply chain management functions by healthcare companies to specialized external providers who handle critical operations such as transportation, warehousing, inventory management, and regulatory compliance. They also offer value-added services, including cold chain handling, real-time tracking, serialization, and reverse logistics, to ensure the safe, efficient, and compliant delivery of temperature-sensitive pharmaceuticals, medical devices, and biologics across the supply chain. The main types of healthcare third-party logistics are cold chain logistics and non-cold chain logistics. Cold chain logistics refers to the transportation and storage of temperature-sensitive products under controlled conditions to maintain their quality, safety, and efficacy throughout the supply chain. It utilizes various modes of transport, including ground transportation, air cargo, and ocean freight. It incorporates different technologies such as automated storage and retrieval systems, warehouse management systems, transportation management systems, blockchain, the internet of things, artificial intelligence and machine learning, and robotics. Temperature control ranges from ambient, controlled, refrigerated, frozen, and cryogenic. These services cater to a wide range of end users, including pharmaceutical and biopharmaceutical companies, hospitals and clinics, medical device manufacturers, research laboratories, healthcare providers, and others.

What Is The Healthcare Third-Party Logistics Market Growth Forecast?

The healthcare third-party logistics market size is expected to see strong growth in the next few years. It will grow to $401.07 billion in 2030 at a compound annual growth rate (CAGR) of 9.1%. The growth in the forecast period can be attributed to increasing investments in smart healthcare logistics platforms, rising demand for cryogenic and ultra-cold storage, expansion of ai-enabled logistics optimization, growing adoption of sustainable transport solutions, increasing focus on resilient healthcare supply chains. Major trends in the forecast period include increasing adoption of cold chain monitoring technologies, rising demand for end-to-end supply chain visibility, growing integration of real-time tracking solutions, expansion of automated healthcare warehousing, enhanced focus on regulatory-compliant logistics.

Global Healthcare Third-Party Logistics Market Segmentation

1) By Type: Cold Chain Logistics, Non-Cold Chain Logistics 2) By Mode Of Transport: Ground Transportation, Air Cargo, Ocean Freight 3) By Technology: Automated Storage And Retrieval Systems, Warehouse Management Systems, Transportation Management Systems, Blockchain, Internet Of Things, Artificial Intelligence And Machine Learning, Robotics 4) By Temperature Control: Ambient, Controlled, Refrigerated, Frozen, Cryogenic 5) By End User: Pharmaceutical And Biopharmaceutical Companies, Hospitals And Clinics, Medical Device Manufacturers, Research Laboratories, Healthcare Providers, Other End Users Subsegments: 1) By Cold Chain Logistics: Refrigerated Storage, Refrigerated Transportation, Packaging Solutions For Temperature-Sensitive Products, Cold Chain Monitoring Systems, Specialized Cold Chain Warehousing 2) By Non-Cold Chain Logistics: Warehousing And Storage, Transportation Management, Inventory Management, Order Fulfillment Services, Packaging And Labeling

What Is The Driver Of The Healthcare Third-Party Logistics Market?

The increasing demand for vaccines is expected to propel the growth of the healthcare third-party logistics market going forward. Vaccines refer to biological preparations that stimulate the body’s immune system to recognize and fight specific diseases by mimicking an infection without causing the illness. The increasing demand for vaccines is due to the rising prevalence of infectious diseases, as more people require protection against widespread health threats. Healthcare third-party logistics supports vaccines by ensuring their safe, timely, and temperature-controlled transportation and storage throughout the supply chain. For instance, in July 2024, the World Health Organization, a Switzerland-based intergovernmental organization, reported that global coverage with the first dose of the HPV vaccine among girls increased from 20% in 2022 to 27% in 2023, with a target of reaching 90% by 2030. Therefore, the increasing demand for vaccines is driving the growth of the healthcare third-party logistics industry.

Key Players In The Global Healthcare Third-Party Logistics Market

Major companies operating in the healthcare third-party logistics market are McKesson Corporation, Cencora Inc, Cardinal Health Inc, Federal Express Corporation, AP Moller Maersk AS, Kuhne And Nagel International AG, Schenker AG, CEVA Logistics India Private Limited, GEODIS SA, Rhenus SE And Co KG, XPO Inc, Agility Logistics Private Limited, Allcargo Logistics Limited, Noatum Logistics India Private Limited, Barrett Distribution Centers Inc, UPS Supply Chain Solutions Inc, Buske Logistics Inc, DHL Supply Chain India Private Limited, Coldman Logistics Private Limited, AmerisourceBergen Logistics Services, DB Schenker Healthcare, Nippon Express Co Ltd

Global Healthcare Third-Party Logistics Market Trends and Insights

Major companies operating in the healthcare third-party logistics market are focusing on developing innovative solutions, such as specialized cell and gene therapy logistics platforms, to ensure the safe, time-critical, and temperature-controlled delivery of advanced therapies. Specialized cell and gene therapy logistics platforms are advanced systems designed to manage the precise, time-sensitive, and temperature-controlled transportation and storage of fragile biological therapies used in personalized medicine. For instance, in October 2024, McKesson Corporation, a US-based healthcare corporation, launched Inspirogene, a specialized business unit designed to facilitate the commercialization of cell and gene therapies through advanced third-party logistics and specialty distribution services. This innovative solution integrates sophisticated supply chain management, temperature-controlled storage, and real-time tracking to ensure product integrity, timely delivery, and efficient distribution of critical vaccines and therapies. Inspirogene offers a flexible platform tailored to the unique logistical demands of cell and gene therapies, streamlining their delivery and supporting their market entry with precision and reliability.

What Are Latest Mergers And Acquisitions In The Healthcare Third-Party Logistics Market?

In April 2025, Morris & Dickson Inc., a US-based pharmaceutical wholesale distribution company, acquired Presa Solutions for an undisclosed amount. With this acquisition, Morris & Dickson Inc. aims to bring an integrated supply chain solution to pharmaceutical and biotech partners, expanding its third-party logistics (3PL) capabilities and offering an alternative to the traditional “Big 3” distributors. Presa Solutions Inc. is a US-based company that provides healthcare third-party logistics (3PL) services.

Regional Outlook

North America was the largest region in the healthcare third-party logistics market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Healthcare Third-Party Logistics Market?

The healthcare third-party logistics market includes revenues earned by entities by providing services such as managing the storage, handling, and delivery of healthcare products, ensuring regulatory compliance, temperature control, secure distribution, and timely delivery to hospitals, clinics, pharmacies, and other healthcare institutions. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Healthcare Third-Party Logistics Market Report 2026?

The healthcare third-party logistics market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the healthcare third-party logistics industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.